Aneuploidy is a condition where a person has an abnormal number of chromosomes. Chromosomes are the structures in our cells that hold our genes, which are instructions for how our bodies grow and function. Most people have 46 chromosomes in each cell, arranged in 23 pairs. When someone has aneuploidy, they might have an extra chromosome or have a missing one.

Here are a few examples to make it clearer:

  • Down Syndrome (Trisomy 21): This is the most common type of aneuploidy. People with Down syndrome have an extra copy of chromosome 21, so they have 47 chromosomes in their cells. This can cause developmental delays and physical traits like a flatter face and upward-slanting eyes.
  • Edwards Syndrome (Trisomy 18): People with this condition have an extra chromosome 18. It can cause severe developmental and health problems, and most affected babies do not survive past their first year.
  • Patau Syndrome (Trisomy 13): This occurs when there is an extra chromosome 13. It also leads to serious health issues, and affected babies often have heart defects and brain abnormalities.
  • Turner Syndrome: This happens when a girl is missing one of her two X chromosomes, so she has 45 chromosomes instead of 46. Girls with Turner syndrome can have short stature and may not develop secondary sexual characteristics without hormone treatment.
  • Klinefelter Syndrome (47, XXY): Boys with this condition have an extra X chromosome, giving them a total of 47 chromosomes. This can affect their physical and cognitive development, often resulting in taller stature and infertility.

These conditions can be detected during pregnancy through special tests. 

Knowing about aneuploidy can help parents and doctors prepare and plan for the best possible care for the baby. These special tests are called Prenatal genetic tests for aneuploidy screening. 

They are essential tools in modern obstetric care, allowing expectant parents and healthcare providers to assess the risk of chromosomal abnormalities in a developing fetus. 

Types of Prenatal Genetic Tests for Aneuploidy

1.Non-Invasive Prenatal Testing (NIPT): It is a screening & not a diagnostic test. Positive results require confirmation with diagnostic tests. It analyzes free fetal DNA (cfDNA)circulating in the mother's blood. It can be performed as early as 10 weeks of gestation.

2.First Trimester Screening: It combines maternal blood tests (measuring levels of pregnancy-associated plasma protein-A (PAPP-A) and human chorionic gonadotropin (hCG)) and a nuchal translucency (NT) ultrasound. It is done Between 11 and 14 weeks of gestation.

3.Second Trimester Screening (Quad Screen): It measures four substances in the mother’s blood: alpha-fetoprotein (AFP), hCG, estriol, and inhibin-A. Timing: Between 15 and 20 weeks of gestation.

4.Combined First and Second Trimester Screening (Integrated Screening): It combines the results of first and second trimester screenings for a more comprehensive risk assessment. It gives a higher accuracy than individual tests.

5.Diagnostic Tests for Aneuploidy: If a screening test indicates a high risk of aneuploidy, diagnostic tests can provide a definitive diagnosis. These tests are invasive and carry a small risk of miscarriage.

  • Chorionic Villus Sampling (CVS): It involves taking a small sample of placental tissue and is done in early                          pregnancy between 10 and 13 weeks of gestation.
  • Amniocentesis: It involves taking a sample of amniotic fluid surrounding the fetus and is typically performed between 15 and 20 weeks of gestation. It is highly accurate, provides information on other conditions beyond aneuploidy.

Conclusion

Prenatal genetic tests for aneuploidy screening have significantly advanced, offering expectant parents' valuable information about the health of their developing fetus. While non-invasive tests like NIPT provide early and accurate risk assessments, invasive diagnostic tests like CVS and amniocentesis remain the gold standard for confirming chromosomal abnormalities. The choice of test depends on various factors, including the stage of pregnancy, risk factors, and personal preferences of the parents